APA Citation

Baxter, M., Yabe, D., Iizuka, K., Watanabe, D., & Kaneto, H. (2021). iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial. Journal of Diabetes Investigation, 12(11), pp. 1992-2001. doi:10.1111/jdi.13563

Chicago Style Citation

Baxter, Michael, Daisuke Yabe, Katsumi Iizuka, Daisuke Watanabe, and Hideaki Kaneto. "IGlarLixi Reduces Residual Hyperglycemia in Japanese Patients With Type 2 Diabetes Uncontrolled On Basal Insulin: A Post‐hoc Analysis of the LixiLan JP‐L Trial." Journal of Diabetes Investigation 12, no. 11 (2021): 1992-2001.

MLA Citation

Baxter, Michael, et al. "IGlarLixi Reduces Residual Hyperglycemia in Japanese Patients With Type 2 Diabetes Uncontrolled On Basal Insulin: A Post‐hoc Analysis of the LixiLan JP‐L Trial." Journal of Diabetes Investigation 12.11 (2021): 1992-2001.

Warning: These citations may not always be 100% accurate.